Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy

Drugs that target immune checkpoints (ICPs) have become the most popular weapons in cancer immunotherapy; however, they are only beneficial for a small fraction of patients. Accumulating evidence suggests that the tumor immune microenvironment (TIME) plays a critical role in anti-cancer immunity. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Tang, Tianyu, Zhang, Gang, Hong, Zhengtao, Xu, Jian, Yadav, Dipesh Kumar, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666137/
https://www.ncbi.nlm.nih.gov/pubmed/33299118
http://dx.doi.org/10.1038/s41698-020-00136-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666137/
https://www.ncbi.nlm.nih.gov/pubmed/33299118
http://dx.doi.org/10.1038/s41698-020-00136-1

Ejemplares similares